Medifast Statistics
Share Statistics
Medifast has 10.99M
shares outstanding. The number of shares has increased by 0.01%
in one year.
| Shares Outstanding | 10.99M |
| Shares Change (YoY) | 0.01% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 81.59% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 324 |
| FTD / Avg. Volume | 0.14% |
Short Selling Information
The latest short interest is 1.15M, so 10.51% of the outstanding
shares have been sold short.
| Short Interest | 1.15M |
| Short % of Shares Out | 10.51% |
| Short % of Float | 10.8% |
| Short Ratio (days to cover) | 5.63 |
Valuation Ratios
The PE ratio is 92.1 and the forward
PE ratio is -26.11.
Medifast's PEG ratio is
-0.94.
| PE Ratio | 92.1 |
| Forward PE | -26.11 |
| PS Ratio | 0.32 |
| Forward PS | 0.3 |
| PB Ratio | 0.92 |
| P/FCF Ratio | 11.31 |
| PEG Ratio | -0.94 |
Financial Ratio HistoryEnterprise Valuation
Medifast has an Enterprise Value (EV) of 117.78M.
| EV / Sales | 0.2 |
| EV / EBITDA | 7.56 |
| EV / EBIT | 4.81 |
| EV / FCF | 6.92 |
Financial Position
The company has a current ratio of 3.34,
with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.34 |
| Quick Ratio | 2.68 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 1.03 |
| Debt / FCF | 0.95 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 1% and Return on Invested Capital is 0.7%.
| Return on Equity | 1% |
| Return on Assets | 0.74% |
| Return on Invested Capital | 0.7% |
| Revenue Per Employee | $1,195,363.1 |
| Profits Per Employee | $4,148.81 |
| Employee Count | 504 |
| Asset Turnover | 2.12 |
| Inventory Turnover | 3.72 |
Taxes
| Income Tax | 1.7M |
| Effective Tax Rate | 44.78% |
Stock Price Statistics
The stock price has increased by -48.82% in the
last 52 weeks. The beta is 0.98, so Medifast's
price volatility has been higher than the market average.
| Beta | 0.98 |
| 52-Week Price Change | -48.82% |
| 50-Day Moving Average | 13.36 |
| 200-Day Moving Average | 16.86 |
| Relative Strength Index (RSI) | 46.39 |
| Average Volume (20 Days) | 235,752 |
Income Statement
In the last 12 months, Medifast had revenue of 602.46M
and earned 2.09M
in profits. Earnings per share was 0.19.
| Revenue | 602.46M |
| Gross Profit | 444.62M |
| Operating Income | 2.88M |
| Net Income | 2.09M |
| EBITDA | 15.59M |
| EBIT | 2.88M |
| Earnings Per Share (EPS) | 0.19 |
Full Income StatementBalance Sheet
The company has 90.93M in cash and 16.13M in
debt, giving a net cash position of 74.8M.
| Cash & Cash Equivalents | 90.93M |
| Total Debt | 16.13M |
| Net Cash | 74.8M |
| Retained Earnings | 176.78M |
| Total Assets | 280.01M |
| Working Capital | 152.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 24.48M
and capital expenditures -7.45M, giving a free cash flow of 17.02M.
| Operating Cash Flow | 24.48M |
| Capital Expenditures | -7.45M |
| Free Cash Flow | 17.02M |
| FCF Per Share | 1.56 |
Full Cash Flow StatementMargins
Gross margin is 73.8%, with operating and profit margins of 0.48% and 0.35%.
| Gross Margin | 73.8% |
| Operating Margin | 0.48% |
| Pretax Margin | 0.63% |
| Profit Margin | 0.35% |
| EBITDA Margin | 2.59% |
| EBIT Margin | 0.48% |
| FCF Margin | 2.83% |
